CD4+ T lymphocytes play a dual role in cancer by activating cytotoxic CD8+ T cells through cytokine release, but under certain conditions, they may also impair CD8+ T cell functionality, contributing to disease progression in HBV-related HCC [58]. The gene discussed is CD4; the disease is cancer.